Metformin + Linagliptin
Information about Metformin + Linagliptin
Metformin + Linagliptin Uses
Metformin+Linagliptin is used in the treatment of type 2 diabetes mellitus.
How Metformin + Linagliptin works
Metformin + Linagliptin is a combination of two antidiabetic medicines: Metformin and Linagliptin. Metformin is an antidiabetic medication (biguanide). It works by lowering the glucose production in the liver, delaying glucose absorption from the intestines and increasing the body's sensitivity to insulin. Linagliptin is a DPP-4 inhibitor which works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces both fasting and postmeal sugar levels. Together, they provide better control of blood sugar.
Common side effects of Metformin + Linagliptin
Diarrhea, Nausea1a, Vomiting, Upset stomach, Headache, Nasal congestion (stuffy nose), Sore throat, Respiratory tract infection, Hypoglycaemia (low blood sugar level) in combination with insulin or sulphonylurea
Available Medicine for Metformin + Linagliptin
Trajenta DuoBoehringer Ingelheim
₹275 to ₹2863 variant(s)
Ondero MetLupin Ltd
₹275 to ₹2863 variant(s)
Expert advice for Metformin + Linagliptin
- Metformin + Linagliptin should be taken with food to lower the chances of having an upset stomach.
- Take it in addition to regular exercise and a healthy diet to lower the levels of blood sugar.
- Chances of weight gain and low blood sugar are lesser as compared to other diabetes medicines.
- Hypoglycemia (low blood sugar level) may occur when taken along with other antidiabetic medicines, alcohol or on delaying/skipping a meal. Carry a sugar source with you for immediate relief.
- Monitor your blood sugar level regularly while you are taking this medicine.
- Inform your doctor about your diabetes treatment if you are due to have any surgery under a general anaesthetic.
- Tell your doctor immediately if you experience any deep or rapid breathing, persistent nausea, vomiting or stomach pain as Metformin + Linagliptin may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid in the blood.